The short version of LC-MS/MS fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-01-29 and is reviewed periodically as new material appears.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C20H24ClN3O4S | Derived from published structure. |
| Molecular weight | 437.94 g/mol | Calculated value. |
| Appearance | White to off-white solid | Typical for purified research samples. |
| Solubility | DMSO, ethanol; low in water | Class: poorly water-soluble. |
| Typical storage | -20 °C, desiccated, protected from light | Limits degradation. |
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
=== Purification === Simulated distillation, a type of gas chromatography testing method used in the petroleum, can be automated via robotics. An older method used a system called ORCA (Optimized Robot for Chemical Analysis) was used for the analysis of petroleum samples by simulated distillation (SIMDIS). ORCA has allowed for shorter analysis times and has reduced maximum temperature needed to elute compounds. One major advantage of automating purification is the scale at which separations can be done. Using microprocessors, ion-exchange separation can be conducted on a nanoliter scale in a short period of time. Robotics have been implemented in liquid-liquid extraction (LLE) to streamline the process of preparing biological samples using 96-well plates. This is an alternative method to solid-phase extraction methods and protein precipitation, which has the advantage of being more reproducible and robotic assistance has made LLE comparable in speed to solid phase extraction. The robotics used for LLE can perform an entire extraction with quantities in the microliter scale and performing the extraction in as little as ten minutes.
The equation displayed on the chart gives a means for calculating the absorbance and therefore concentration of the unknown samples. In Graph 1, x is concentration and y is absorbance, so one must rearrange the equation to solve for x and enter the absorbance of the measured unknown. It is likely that the unknown will have absorbance numbers outside the range of the standard. These should not be included calculations, as the equation given cannot apply to numbers outside of its limitations. In a large scale, one must compute the extinction coefficient using the Beer-Lambert Law A=εLC in which A is the measured absorbance, ε is the slope of the standard curve, L is the length of the cuvette, and C is the concentration being determined. In a micro scale, a cuvette may not be used and therefore one only has to rearrange to solve for x.
The most common side effects reported with vortioxetine are nausea, vomiting, constipation, and sexual dysfunction, among others. With the exceptions of nausea and sexual dysfunction, these side effects were reported by less than or equal to 10% of study participants given vortioxetine. Significant percentages of placebo-treated participants also report these side effects. Discontinuation of treatment due to adverse effects in clinical trials was 8% with vortioxetine versus 3% with placebo. Sexual dysfunction, such as decreased libido, abnormal orgasm, delayed ejaculation, and erectile dysfunction, are well-known side effects of SSRIs and serotonin–norepinephrine reuptake inhibitors (SNRIs). In clinical trials, sexual dysfunction occurred more often with vortioxetine than with placebo and appeared to be dose-dependent. Incidence of treatment-emergent sexual dysfunction as measured with the Arizona Sexual Experience Scale (ASEX) were 14 to 20% for placebo and 16 to 34% for vortioxetine over a dosage range of 5 to 20 mg/day. The incidence of sexual dysfunction with vortioxetine was similar to that with the SNRI duloxetine, which had an incidence of 26 to 28% at the used dosage of 60 mg/day. However, treatment-emergent sexual dysfunction caused by a prior SSRI was better improved by switching to vortioxetine than by switching to the SSRI escitalopram. In another study, vortioxetine at a dosage of 10 mg/day though not at 20 mg/day produced less sexual dysfunction than the SSRI paroxetine.
Sources: en.wikipedia.org
The uprising may have been significant for the organisational development and strategy of the UDF. Over the course of the first year of the uprising, an internal debate was settled in favour of the front taking on a more expansive role, which would go beyond campaign-based protest and opposition to the Tricameral Parliament. Thus in 1985, the front declared its proposal to move "from mobilisation to organisation" through a programme to strengthen its organisational structures and discipline, including through increased accountability and representation for local affiliates. Similarly, at the grassroots level, by 1986 there was a movement in many black townships to re-establish political discipline, including by persuading students to return to school and subjecting them to the authority of strong local civic associations which included representations for elders. Moreover, historians of South Africa's trade union movement often view the Vaal uprising as an inflection point in the politicisation (or re-politicisation) of the major trade unions. According to Eddie Webster, the November 1984 stay-away marked "the beginning of united mass action between organised labour, students and community organisations". The Charterist Congress of South African Trade Unions was founded in late 1985 and went on to play a crucial role in the Mass Democratic Movement.
metabolite An intermediate or end product of metabolism, especially degradative metabolism (catabolism); or any substance produced by or taking part in a metabolic reaction. Metabolites include a huge variety of small molecules generated by cells from various pathways and having various functions, including as inputs to other pathways and reactions, as signaling molecules, and as stimulators, inhibitors, and cofactors of enzymes. Metabolites may result from the degradation and elimination of naturally occurring compounds as well as of synthetic compounds such as pharmaceuticals.
== Etymology == The name derives from the Ancient Greek word πολύς (polus, meaning "many, much") and the word 'phenol' which refers to a chemical structure formed by attachment of an aromatic benzenoid (phenyl) ring to a hydroxyl (-OH) group (hence the -ol suffix). The term "polyphenol" has been in use at least since 1894.
=== 26 May === One person was killed in a Russian attack in Kharkiv Oblast. Three people were killed in separate attacks in Donetsk Oblast. A terminal of Zaporizhzhia International Airport was destroyed in a Russian missile attack. Ukrainian media reported that an HUR drone struck a Russian early-warning Voronezh M radar system in Orsk, Orenburg Oblast after travelling a distance of some 1,800 kilometres. Satellite images taken on 27 May appear to show burn marks, confirming the attack. The radar is part of the Russian nuclear early warning for air- and space-based threats such as ballistic missiles and bombers. Swedish Defence Minister Pål Jonson said that Ukraine had the right to strike targets on Russian soil, provided that it "comply with the laws of war".
Sources: en.wikipedia.org
== External links == International Society for Condensed Matter Nuclear Science (iscmns.org), organizes the ICCF conferences and publishes the Journal of Condensed Matter Nuclear Science. See: library.htm of published papers and proceedings. Low Energy Nuclear Reactions (LENR) Phenomena and Potential Applications Archived 7 October 2015 at the Wayback Machine: Naval Surface Warfare Center report NSWCDD-PN-15-0040 by Louis F. DeChiaro, PhD, 23 September 2015
=== 1991–1996: Early work and breakthrough === DiCaprio made his film debut in 1991 as the stepson of an unscrupulous landlord in the low-budget horror sequel Critters 3—a part he later described as "your average, no-depth, standard kid with blond hair". DiCaprio has stated that he prefers not to remember Critters 3, viewing it as "possibly one of the worst films of all time" and the kind of role he wanted to avoid in the future. Later in 1991, he became a recurring cast member on the sitcom Growing Pains, playing Luke Brower, a homeless boy who is taken in by the show's central family. Co-star Joanna Kerns recalls DiCaprio being "especially intelligent and disarming for his age" but she noted that he was also mischievous and jocular on set, and often made fun of his co-stars. DiCaprio was cast by the producers to appeal to young female audience, but his arrival did not improve the show's ratings and he left before the end of its run. He was nominated for a Young Artist Award for Best Young Actor Co-starring in a Television Series. DiCaprio also had an uncredited role in 1991 in one episode of Roseanne.
Obsidian (, əb-SID-ee-ən ob-) is a naturally occurring volcanic glass formed when lava extruded from a volcano cools rapidly with minimal crystal growth. It is an igneous rock. Produced from felsic lava, obsidian is rich in the lighter elements such as silicon, oxygen, aluminium, sodium, and potassium. It is commonly found within the margins of rhyolitic lava flows known as obsidian flows. These flows have a high content of silica, giving them a high viscosity. The high viscosity inhibits the diffusion of atoms through the lava, which inhibits the first step (nucleation) in the formation of mineral crystals. Together with rapid cooling, this results in a natural glass forming from the lava. Obsidian is hard, brittle, and amorphous; it therefore fractures with very sharp edges. In the past, it was used to manufacture cutting and piercing tools, and it has been used experimentally as surgical scalpel blades.
Sources: en.wikipedia.org
SR9009 is a synthetic REV-ERB agonist used in laboratory research. It is not an approved drug, and its effects in humans are not well characterized. It is often sold as a research chemical under the name Stenabolic.
No. SR9009 targets the nuclear receptors REV-ERBα and REV-ERBβ, not the androgen receptor. This mechanism differs from selective androgen receptor modulators and from exercise mimetics that act on PPARδ.
Published evidence is mainly preclinical, using cell cultures and animal models. Controlled human trials are not well documented in the public literature. Claims about human performance or health effects therefore remain unsupported by robust clinical data.
Liquid chromatography-tandem mass spectrometry is a common approach. It can detect the parent compound and its metabolites in biological matrices.